Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism.

Department of Surgery, Division of General Surgery, University of Calgary, Foothills Medical Center, 1403 29th Street NW, Calgary, Alberta, Canada T2N 2T9.
World Journal of Surgery (Impact Factor: 2.35). 08/2002; 26(8):942-9. DOI: 10.1007/s00268-002-6623-y
Source: PubMed

ABSTRACT This study assessed the impact of parathyroidectomy on the preoperative symptoms of patients with primary hyperparathyroidism (1 degrees HPT) using a surgical outcome tool designed specifically for HPT. The multicenter nature of this study allowed us to validate further this disease-specific outcome tool. 1 degrees HPT patients from Canada, the United States, and Australia filled out the questionnaire preoperatively and postoperatively on day 7 and at 3 and 12 months. The symptoms recorded by the patients were expressed as parathyroidectomy assessment of symptoms (PAS) scores: the higher the score, the more symptomatic is the patient. Quality of Life (QOL) and self-rated health uni-scales were included. Altogether, 203 patients with 1 degrees HPT were enrolled; 27 from center A, 54 from center B, and 122 from center C; 58 nontoxic thyroid patients were enrolled for comparison. The comparison group had no significant change in their PAS scores throughout the study (scores 184, 215, 156, 186). All three centers demonstrated a significant reduction in symptoms following surgery. The median preoperative PAS score from center B patients was 282. Following surgery, PAS scores decreased significantly: 136, 58, 0 (p <0.05). Center C patients had a median preoperative PAS score of 344, decreasing postoperatively to 228 (p <0.05) and continuing to decrease to 190, then 180. Center A also demonstrated a significant reduction in symptoms at 3 months, from 510 preoperatively to 209 (p <0.001). Both QOL and self-rated health improved in the HPT patients, whereas no change was found in the comparison group following surgery. PAS scores are a reliable, disease-specific measure of symptoms seen with HPT. Parathyroidectomy significantly reduces these preoperative symptoms, and this change translated into an improved health-related QOL for the patients.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Previous studies have shown that parathyroidectomy for primary hyperparathyroidism (PHPT) improve the function and quality of life of patients. The aim of this systematic review and meta-analysis is to determine the health-related quality of life outcomes among those having surgical management for PHPT. Methods: Several databases were searched (MEDLINE, EMBASE, PubMed, Current Contents) for studies in which health-related quality of life was measured by reliable and validated instruments (SF-36 and Paseika Questionnaire) before and after parathyroidectomy for patients with primary hyperparathyroidism (PHPT). For the SF-36, score differences greater than 5 points indicate clinically relevant changes. Results: There were six studies with quality of life data. The SF-36 data was derived from 238 patients, with a mean age of 59 years and 71% were females. The range of follow up after surgery was 6 months to one year. The pre- and post-parathyroidectomy SF-36 quality of life scale scores were vitality (44 vs. 60, p < 0.001), physical functioning (51 vs. 69, p < 0.001), bodily pain (50 vs. 65, p < 0.001), general health (54 vs. 64, p < 0.001), role physical (34 vs. 52, p < 0.001), role emotional (43 vs. 59, p < 0.001), role social (60 vs. 74, p < 0.001), and mental health (55 vs. 71, p < 0.001). The Paseika data was derived from 203 patients, with a mean age of 54 years and 67% were females. The pre- and post-parathyroidectomy Paseika scores were feeling tired (51 vs. 19, p < 0.001), feeling thirsty (29 vs. 12, p < 0.001), mood swings (33 vs. 12, p < 0.001), joint pains (32 vs. 14, p < 0.001), irritability (31 vs. 10, p < 0.001), feeling blue (31 vs. 14, p < 0.001), feeling weak (37 vs. 15, p < 0.001), itchy (17 vs. 7, p < 0.001), forgetful (27 vs. 16, p < 0.001), headache (18 vs. 5, p < 0.001), abdominal pain (19 vs. 8, p < 0.001), bone pain (38 vs. 17, p < 0.001), ability to move off chair (27 vs. 11, p < 0.001). Conclusion: Parathyroidectomy significantly improves the short to medium-term health-related quality of life of patients suffering from primary hyperparathyroidism. Crown Copyright © 2014. Published by Elsevier Ltd. All rights reserved.
    International Journal of Surgery (London, England) 12/2014; 13. DOI:10.1016/j.ijsu.2014.12.004 · 1.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fibromyalgia (FM), an ill-defined symptom complex, is characterized by musculoskeletal pain, headache, depression, fatigue, and cognitive decline, symptoms also seen commonly in primary hyperparathyroidism (PHP). Prevalence of concurrent PHP and FM and response to parathyroidectomy (PTX) of those with both conditions are unknown. We reviewed prospective data of 4,000 patients with sporadic PHP who had PTX from 1995 to 2013 examining perioperative symptoms and medication usage for those with diagnosed FM. Cure was defined by normocalcemia at ≥6 months. Of 2,184 patients, 80 (4%) had a prior diagnosis of FM. Of evaluable FM patients, 97.3% had definitive cure of PHP. After PTX, 89% had improvement in ≥1 symptom attributed to FM, with improved cognition/memory most common (80%). Improvement in ≥2, ≥3, and ≥4 FM symptoms was appreciated by 71%, 43%, and 25%, respectively. Quality of life and wellness improved in >50%. Postoperative use of drugs prescribed for FM often improved or resolved (narcotics, 77%; anti-inflammatories, 74%; "FM-specific medications," 33%; antidepressants, 30%); 21% discontinued all FM medications postoperatively. FM is common in patients operated on for sporadic PHP. Of those with both conditions, after PTX 89% appreciate symptom response and 77% and 21% had a decrease in or discontinuation or medications, respectively. Before diagnosing FM, providers should exclude PHP, which is surgically correctable. Copyright © 2014 Elsevier Inc. All rights reserved.
    Surgery 12/2014; 156(6):1614-21. DOI:10.1016/j.surg.2014.08.063 · 3.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, a gate-all-around Si Nanowire FET (NWFET) and InAs NWFET have been studied and compared with respect to various performance parameters. The device metrics considered at the nanometer scale are transfer characteristics, transconductance, output characteristics, drive and leakage current, switching speed (Ion/Ioff), conduction-band profile, subthreshold swing (SS) and drain induced barrier lowering (DIBL). It has been shown that InAs channeled NWFET has higher mobility and hence higher transconductance, whereas Si NWFET shows better immunity towards short channel effects with lower leakage current, lower sub-threshold slope, lower DIBL. Therefore, Si NWFET appears to be applicable for Low Operating Power applications whereas, InAs with its high ON currents and switching speeds prove to be a good candidate for high performance applications of the long term ITRS where reasonably high leakage currents are acceptable as a trade off for increased operating speeds.
    2014 International Conference on Signal Propagation and Computer Technology (ICSPCT); 07/2014